Prophase Labs Inc is a biotechnology company focused on developing and commercializing innovative healthcare solutions, particularly in the fields of over-the-counter pharmaceuticals and medical devices
The company leverages its expertise in scientific research and product development to create high-quality consumer health products aimed at improving patient outcomes. Prophase Labs is dedicated to advancing health and wellness through its commitment to safety, efficacy, and accessibility, while actively pursuing opportunities in both established and emerging markets to expand its portfolio and reach.
NEW YORK, NY / ACCESS Newswire / March 18, 2025 / The Investor Summit is excited to announce that presentations from Q1 Investor Summit are now available for on-demand viewing. Attendees and investors who missed the live sessions can now access company presentations at their convenience.
Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report.
Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
Curious to know what's happening on the US markets in the middle of the day on Thursday? Join us as we explore the top gainers and losers in today's session.
ProPhase Labs shares are trading lower by 50% during Friday's session. The company announced a 4.17 million share offering at 72 cents per share, totaling $3 million.
